chr6-146434706-C-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001278064.2(GRM1):​c.3495C>A​(p.Pro1165Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.529 in 1,602,804 control chromosomes in the GnomAD database, including 226,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24251 hom., cov: 33)
Exomes 𝑓: 0.53 ( 202436 hom. )

Consequence

GRM1
NM_001278064.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -7.05

Publications

17 publications found
Variant links:
Genes affected
GRM1 (HGNC:4593): (glutamate metabotropic receptor 1) This gene encodes a metabotropic glutamate receptor that functions by activating phospholipase C. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The canonical alpha isoform of the encoded protein is a disulfide-linked homodimer whose activity is mediated by a G-protein-coupled phosphatidylinositol-calcium second messenger system. This gene may be associated with many disease states, including schizophrenia, bipolar disorder, depression, and breast cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
GRM1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 44
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive spinocerebellar ataxia 13
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 6-146434706-C-A is Benign according to our data. Variant chr6-146434706-C-A is described in ClinVar as Benign. ClinVar VariationId is 129213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-7.05 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.666 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM1NM_001278064.2 linkc.3495C>A p.Pro1165Pro synonymous_variant Exon 8 of 8 ENST00000282753.6 NP_001264993.1 Q13255-1Q59HC2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM1ENST00000282753.6 linkc.3495C>A p.Pro1165Pro synonymous_variant Exon 8 of 8 1 NM_001278064.2 ENSP00000282753.1 Q13255-1

Frequencies

GnomAD3 genomes
AF:
0.559
AC:
84959
AN:
152006
Hom.:
24226
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.673
Gnomad AMI
AF:
0.471
Gnomad AMR
AF:
0.492
Gnomad ASJ
AF:
0.565
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.603
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.523
Gnomad OTH
AF:
0.562
GnomAD2 exomes
AF:
0.520
AC:
124677
AN:
239870
AF XY:
0.524
show subpopulations
Gnomad AFR exome
AF:
0.678
Gnomad AMR exome
AF:
0.396
Gnomad ASJ exome
AF:
0.573
Gnomad EAS exome
AF:
0.515
Gnomad FIN exome
AF:
0.447
Gnomad NFE exome
AF:
0.519
Gnomad OTH exome
AF:
0.526
GnomAD4 exome
AF:
0.526
AC:
762612
AN:
1450680
Hom.:
202436
Cov.:
48
AF XY:
0.528
AC XY:
381525
AN XY:
722168
show subpopulations
African (AFR)
AF:
0.676
AC:
22641
AN:
33468
American (AMR)
AF:
0.405
AC:
18097
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.568
AC:
14839
AN:
26130
East Asian (EAS)
AF:
0.496
AC:
19699
AN:
39694
South Asian (SAS)
AF:
0.600
AC:
51715
AN:
86252
European-Finnish (FIN)
AF:
0.447
AC:
19058
AN:
42644
Middle Eastern (MID)
AF:
0.570
AC:
3284
AN:
5766
European-Non Finnish (NFE)
AF:
0.522
AC:
580619
AN:
1111686
Other (OTH)
AF:
0.541
AC:
32660
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
22342
44683
67025
89366
111708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16696
33392
50088
66784
83480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.559
AC:
85025
AN:
152124
Hom.:
24251
Cov.:
33
AF XY:
0.555
AC XY:
41276
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.673
AC:
27929
AN:
41494
American (AMR)
AF:
0.491
AC:
7515
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.565
AC:
1961
AN:
3472
East Asian (EAS)
AF:
0.521
AC:
2684
AN:
5154
South Asian (SAS)
AF:
0.604
AC:
2915
AN:
4826
European-Finnish (FIN)
AF:
0.447
AC:
4737
AN:
10594
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.522
AC:
35515
AN:
67972
Other (OTH)
AF:
0.566
AC:
1196
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1915
3830
5746
7661
9576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.501
Hom.:
5145
Bravo
AF:
0.563
Asia WGS
AF:
0.579
AC:
2014
AN:
3478
EpiCase
AF:
0.535
EpiControl
AF:
0.536

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive spinocerebellar ataxia 13 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia 44 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.31
DANN
Benign
0.90
PhyloP100
-7.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9373491; hg19: chr6-146755842; COSMIC: COSV51124985; API